Click to Enlarge
Facebook
Twitter
The Times also leads with the pause in giving out the Oxford jab to children. The Oxford team who are running the trial on children say they had seen no specific safety concerns, the paper says. The Times adds that European regulators are about to decide imminently whether evidence suggests a causal link between the vaccine and blood clots.